Clinical Trials Browser

Phase 1/2 × Leiomyosarcoma × Trabectedin × Clear all

NCT02275286 2023-05-31

TRASTS

Phase 1/2 Recruiting

Leiomyosarcoma, Liposarcoma, Sarcoma, Liposarcoma, Myxoid

NCT03074318 2022-04-29

Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery

Phase 1/2 Terminated

35 enrolled 21 charts

Leiomyosarcoma, Liposarcoma